Scottish Health Board Launches UK-First Miscarriage Cradle Initiative
In a groundbreaking move, NHS Greater Glasgow and Clyde (NHSGGC) is set to become the first health board in the United Kingdom to fully implement the rollout of miscarriage collection cradle kits. This innovative medical device, designed to provide greater care and dignity to individuals experiencing pregnancy loss, will be introduced across multiple hospital sites starting this year.
Inspired by Personal Tragedy
The cradle was developed by Dignity Care, a company founded by Laura Corcoran, a former NHS engineer who was motivated to create the device after her own miscarriage. Corcoran shared, "When I experienced miscarriage at home, I faced an incredibly difficult situation without the right support. That deeply personal experience led me to design something that could help others navigate the practical and emotional challenges with greater care and dignity."
How the Device Works
The miscarriage collection cradle is engineered to fit beneath a standard toilet seat, offering an alternative to surgical procedures. It allows women to manage their loss at home or in hospital settings, while also preserving pregnancy tissue for genetic testing. This testing can provide crucial insights into the causes of miscarriage, potentially aiding families in understanding their loss.
Benefits and Implementation
Key advantages of the cradle include:
- Reducing contamination and emotional distress during the miscarriage process.
- Enhancing the quality of genetic samples compared to surgical methods, which could improve testing success rates.
- Freeing up surgical resources, with estimates suggesting annual savings of £6.7m to £11.2m and the liberation of 7,300 to 12,000 surgery slots.
Nikki Harvey, lead nurse for gynaecology and early pregnancy at NHSGGC, stated, "We understand how upsetting a miscarriage can be for many women, and we have processes in place to ensure they feel supported. We're pleased to be gradually introducing the collection cradle, offering it where clinically appropriate, starting with the Royal Alexandra Hospital and expanding to other sites."
Broader Impact and Support
Research indicates that one in three women with pregnancy loss visit A&E, yet one in five are turned away without treatment, highlighting the need for compassionate support. The rollout, backed by £1.5 million in Scottish government funding, will begin at the Royal Maternity Unit before extending to the Queen Elizabeth University Hospital and Princess Royal Maternity Hospital. This initiative represents the first full integration of such devices across multiple UK hospital sites, ensuring guaranteed access for eligible patients over the coming year.
